<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Mesenchymal stem cell (MSC) transplantation has been reported to improve neurologic function after ischemic injury </plain></SENT>
<SENT sid="1" pm="."><plain>However, the detailed mechanisms by which MSCs promote functional recovery are not fully understood </plain></SENT>
<SENT sid="2" pm="."><plain>Interleukin-10 (IL-10) is a well-known anti-inflammatory cytokine with neuroprotective effects with respect to brain injury </plain></SENT>
<SENT sid="3" pm="."><plain>In this study, a non-human primate <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> model was used to test the hypothesis that transplanted human bone-marrow-derived MSCs (hBMSCs) exert a neuroprotective effects on <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> and upregulate IL-10 expression </plain></SENT>
<SENT sid="4" pm="."><plain>We also assessed neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and astroglial activity in the area around the ischemic lesion and proliferating cells in the subventricular zone (SVZ) </plain></SENT>
<SENT sid="5" pm="."><plain>Results showed that hBMSC transplantation in ischemic tissues improved the neurological functions and induced an increase in IL-10 expression </plain></SENT>
<SENT sid="6" pm="."><plain>In addition, neuronal <z:mpath ids='MPATH_3'>apoptosis</z:mpath> and astroglial activity in the peri-ischemic area decreased, and the number of proliferating cells in the SVZ increased </plain></SENT>
<SENT sid="7" pm="."><plain>These results provide a novel therapeutic strategy for improving neurologic function after <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
</text></document>